Product
Trivalent Influenza Vaccine A
1 clinical trial
1 indication
Indication
InfluenzaClinical trial
Immunogenicity and Safety of a Quadrivalent Influenza Vaccine in Participants Aged Above 3 YearsStatus: Completed, Estimated PCD: 2019-10-08
1 clinical trial
1 indication